TFB Advisors LLC Lowers Holdings in Aflac Incorporated (NYSE:AFL)

TFB Advisors LLC lessened its position in Aflac Incorporated (NYSE:AFL) by 2.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 10,202 shares of the financial services provider’s stock after selling 246 shares during the period. TFB Advisors LLC’s holdings in Aflac were worth $1,141,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Y.D. More Investments Ltd bought a new stake in Aflac in the 2nd quarter worth approximately $25,000. Cedar Wealth Management LLC bought a new stake in shares of Aflac in the first quarter worth $50,000. Catalyst Capital Advisors LLC bought a new stake in shares of Aflac in the third quarter worth $51,000. Fairscale Capital LLC bought a new position in Aflac in the second quarter valued at about $54,000. Finally, Valued Wealth Advisors LLC grew its stake in shares of Aflac by 116.7% during the 3rd quarter. Valued Wealth Advisors LLC now owns 479 shares of the financial services provider’s stock valued at $54,000 after purchasing an additional 258 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. Barclays started coverage on shares of Aflac in a report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price objective on the stock. Bank of America upped their price objective on Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a research note on Thursday, October 10th. Truist Financial boosted their price target on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a report on Friday, November 1st. JPMorgan Chase & Co. lifted their price objective on Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. Finally, Morgan Stanley raised their target price on shares of Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research note on Monday, August 19th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Aflac currently has a consensus rating of “Hold” and an average target price of $97.93.

Aflac Price Performance

Shares of Aflac stock opened at $107.44 on Friday. The stock has a market cap of $59.69 billion, a price-to-earnings ratio of 16.18, a price-to-earnings-growth ratio of 2.06 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.10 and a current ratio of 0.08. The stock has a 50 day moving average price of $110.42 and a 200-day moving average price of $98.32. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping the consensus estimate of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. Aflac’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.84 earnings per share. Equities analysts expect that Aflac Incorporated will post 7.05 EPS for the current year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.86%. The ex-dividend date is Wednesday, November 20th. Aflac’s payout ratio is currently 30.12%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.